A 75-year-old woman was found to be unconscious in hospital. She was febrile with a temperature of 38.4 . She had hypotension (blood pressure 80/40 mmHg) with serum Na 132 mEq/L and K 5.7 mEq/L (serum Na/K = 23.2), and serum cortisol 0.91 μg/dL, indicative of adrenal failure. She was admitted for the treatment of Graves' hyperthyroidism, and was found to be unconscious in hospital. We encountered a patient with unrecognized adrenocortical disease, in whom development of Graves' hyperthyroidism caused an adrenal crisis. The ACTH stimulation test indicated that she had 21-hydroxylase deficiency (21OHD); after ACTH stimulation, 17-OH-progesterone increased from 0.6 to 10.4 ng/mL (17.3 times), and 17-OHprogesterone/cortisol from 0.0049 to 0.045 (9.2 times). She did not have clinical signs of classical 21OHD. She had non-classical 21OHD (NC21OHD). Development of Graves' hyperthyroidism caused an adrenal crisis in a patient with previously unrecognized NC21OHD.
Introduction
Thyroxine replacement without adrenal steroid replacement can precipitate an adrenal crisis in patients with impaired TSH and ACTH secretions (pituitary insufficiency) and also in patients with hypothyroidism and adrenocortical insufficiency (1) . Primary hypothyroidism due to Hashimoto's thyroiditis and hypoadrenalism due to Addison's disease may occur concomitantly as part of autoimmune endocrine syndromes (2). Schmidt's syndrome is an autoimmune polyglandular syndrome first used to describe patients with both Hashimoto's thyroiditis and Addison's disease (3, 4) . Today, the term Schmidt's syndrome is used synonymously with autoimmune polyglandular syndrome type II (2) . Thyroxine replacement without adrenal steroid replacement can precipitate an adrenal crisis in this group of patients (1) . It is less widely appreciated that similar problems may arise during thyroxine treatment of hypothyroidism if the patient also has unrecognized or subclinical adrenocortical disease (5) . Thyroxine treatment can precipitate an adrenal crisis in patients with subclinical adrenal insufficiency. Thyroxine unmasks Addison's disease (6) . Graves' hyperthyroidism has been expected to precipitate an adrenal crisis if the patient has unrecognized or subclinical adrenocortical disease. However, it has not been reported that Graves' hyperthyroidism causes an adrenal crisis in patients with unrecognized or subclinical adrenocortical disease. We have seen a patient with unrecognized adrenocortical disease, in whom development of Graves' hyperthyroidism caused an adrenal crisis. She had non-classical 21-hydroxylase deficiency (NC 21OHD). 
T a b l e 1 . T h y r o i d F u n c t i o n T e s t s a n d S e r u m S o d i u m ( Na ) a n d P o t a s s i u m ( K) L e v e l s a t t h e T i me o f Ad mi s s i o n ( Da y 1 ) , Ad r e n a l Cr i s i s ( Da y 4 ) , a n d T h e r e a f t e r

Case Report
A 75-year-old Japanese woman was admitted for the treatment of Graves' hyperthyroidism (Day 1, Table 1 ). She was found to be unconscious in hospital on Day 4. She was febrile with a temperature of 38.4 . She had hypotension (blood pressure 80/40 mmHg) with serum Na 132 mEq/L and K 5.7 mEq/L (serum Na/K=23.2), and serum cortisol 0.91 μg/dL, indicative of adrenal failure.
She was admitted with a one-month history of palpitation, finger tremor, excessive sweating, moist skin, and body weight loss (Day 1, Table 1 ). She had tachycardia, finger tremor, and a goiter. Thyroid function study revealed that she had hyperthyroidism. She had positive TSH receptor antibody (TRAb). A diagnosis of Graves' hyperthyroidism was made on the basis of history and signs of hyperthyroidism with diffuse goiter and the laboratory findings, including elevated serum free thyroxine (free T4: fT4) and free triiodothyronine (free T3: fT3) concentrations, undetectable serum TSH, and positive TRAb. Ultrasonography demonstrated enlargement of the thyroid glands and color doppler sonography demonstrated increased intrathyroid blood flow. She had positive thyroglobulin antibody (TgAb) (26.0 U/ mL; reference values were less than 0.3 U/mL) and negative thyroid peroxidase antibody (TPOAb) (0.2 U/mL; reference values were less than 0.3 U/mL). Her serum Na was 139 mEq/L and serum K was 5.0 mEq/L (Na/K=27.8). Her complete blood count revealed hemoglobin of 11.2 g/dL and white cell count of 4,100/μL with normal differential. Her remaining biochemical results were within normal limits. She was admitted for the treatment of Graves' hyperthyroidism. On admission, she was well-oriented and fully conscious. Her height was 150 cm and her weight was 48.9 kg. She was afebrile with a temperature of 36.1 . Her blood pressure was 120/68 mmHg. She had tachycardia (110/min). She also had finger tremor. Her skin was moist. She had a goiter. Mild lid-lag sign was present, however, without any obvious orbitopathy. There was no pigmentation of the cheek or skin. Secondary sexual characteristics were well preserved. Systemic examination did not elicit any abnormality. At the age of 72 years old, she was found to have gallbladder cancer. Cholecystectomy was done. She tolerated the procedures well. Otherwise, she had been well until one month prior to admission, when she began to have palpitation and excessive sweating. She developed Graves' hyperthyroidism. She had no episodes of dehydration. She denied any histories of hypotension, hypoglycemia, hyponatremia, or hyperkalemia. She has two children, a son and a daughter. Her daughter also had Graves' hyperthyroidism. No family history of 21-hydroxylase deficiency (21OHD) was obtained.
She was found to be unconscious in hospital on the 4th hospital day (Day 4, Table 1 ). She was febrile with a temperature of 38.4 . She had hypotension (80/40 mmHg) with serum Na 132 mEq/L and K 5.7 mEq/L (Na/K=23.2), (Fig. 1) . Congenital adrenal hyperplasia (CAH) was suspected. CT and magnetic resonance imaging (MRI) did not reveal any abnormalities in the pituitary gland. Endocrine study was done 14 days after the discontinuation of the hydrocortisone replacement therapy (Day 26, Table 1 ). Basal hormone levels at 9:00 were in the normal reference ranges ( Table 2 ). She had enlargement of bilateral adrenal glands, and was thought to have congenital adrenal hyperplasia (CAH). Eighteen days after the discontinuation of hydrocortisone (Day 30, Table 1 ), a rapid ACTH stimulation test was performed (Table 3) ; 0.25 mg ACTH (cortrosyn) was administered intravenously. A baseline ACTH level (21.9 pg/mL) was normal. Elevations in cortisol levels after ACTH stimulation were greater than 18 μg/dL within 60 minutes (Table 3A) ; cortisol responses to ACTH stimulation were normal. After ACTH stimulation, 17-hydroxyprogesterone (17-OH-progesterone) increased from 0.6 to 10.4 ng/mL (17.3 times), 17-hydroxypregnenolone (17-OH-pregnenolone) from 0.33 to 5.22 ng/ mL (15.8 times), progesterone from 0.06 to 0.21 ng/mL (3.5 times), cortisol from 12.2 to 23.1 μg/dL (1.9 times), 17-OHprogesterone/corisol from 0.0049 to 0.045 (9.2 times), T a b l e 3 . Ra p i d ACT H-s t i mu l a t i o n T e s dehydroepiandrosterone-sulfate (DHEA-S) from 29.4 to 358 μg/dL (12.2 times), and androstenedione from 0.4 to 3.6 ng/ mL (9.0 times) (Table 3B ). These results indicated that she had 21-hydroxylase deficiency (21OHD). She did not have clinical signs of classical 21OHD. She had non-classical 21 OHD (NC21OHD). She did not have any episodes of an adrenal insufficiency during the 18 days after the discontinuation of hydrocortisone.
F i g u r e 1 . Ab d o mi n a l c o mp u t e d t o mo g r a p h y ( CT ) s h o we d e n l a r g e me n t o f b i l a t e r a l a d r e n a l g l a n d s . Ri g h t a d r e n a l ( Y s h a p e ) ; l e n g t h 3 6 mm, t h i c k n e s s 1 2 mm, a n d wi d t h 2 6 mm. L e f t a d r e n a l ( Y s h a p e ) ; l e n g t h 2 7 mm, t h i
A 75-year-old woman with NC21OHD developed Graves' hyperthyroidism. This development of Graves' hyperthyroidism caused an adrenal crisis. The adrenal crisis was successfully treated with intravenous administration of hydrocortisone and fluids. Graves' hyperthyroidism was also successfully treated with MMI. Since then her condition remains stable. She is now on hydrocortisone (HC) and MMI.
Materials and Methods
Hormone assays
Serum TSH, free T3, and free T4 were determined by electrochemiluminescence immunoassays (ECLIA). Serum TSH receptor antibody (TRAb) (TRAb [human]) was determined by a radioreceptor assay (RRA). Thyroglobulin antibody (TgAb) and thyroid peroxidase antibody (TPOAb) were determined by radioimmunoassays (RIA). Plasma ACTH was determined by an electrochemiluminescence immunoassay (ECLIA). Plasma cortisol and aldosterone were determined by RIA. Serum dehydroepiandrosterone-sulfate (DHEA-S) was determined by a chemiluminescence enzyme immunoassay (CLEIA). Serum 17-OH-pregnenolone, 17-OH-progesterone, 11-deoxycortisol, deoxycorticosterone (DOC), and androstenedione were determined by RIA. Plasma renin concentration (PRC) was determined by RIA. Serum testosterone was determined by an electrochemiluminescence immunoassay (ECLIA). Prolactin, LH, and FSH were measured by chemiluminescence immunoassay (CLIA). GH was measured by RIA. Hormone assays were done at SRL Institute (Tokyo, Japan). Normal reference ranges for hormone concentrations are described in the tables or elsewhere.
Others
An ACTH stimulation test was performed using 0.25 mg tetracosactide acetate (Cortrosyn). Written informed consent was obtained from the patient for publication of this case report.
Discussion
We encountered a patient with unrecognized adrenocortical disease, in whom development of Graves' hyperthyroidism caused an adrenal crisis. The ACTH stimulation test indicated that she had 21-hydroxylase deficiency (21OHD). She did not have clinical signs of classical 21OHD. She had non-classical 21OHD (NC21OHD). Development of Graves' hyperthyroidism caused an adrenal crisis in a patient with NC21OHD. Thyroxine replacement without adrenal steroid replacement can precipitate an adrenal crisis in patients with hypothyroidism and adrenal insufficiency. Thyroxine unmasks Addison's disease (6) . Graves' hyperthyroidism has been expected to precipitate an adrenal crisis if the patient has unrecognized or subclinical adrenocortical disease. However, Graves' hyperthyroidism has not been reported as a cause of adrenal crisis in patients with unrecognized or subclinical adrenocortical disease. A patient with unrecognized adrenocortical disease developed Graves' hyperthyroidism, which induced an adrenal crisis. She had NC21OHD. Development of Graves' hyperthyroidism caused an adrenal crisis in a patient with previously unrecognized NC21OHD.
There are three forms of 21-hydroxylase deficiency (21 OHD) (7); [1] classical salt-wasting 21OHD, [2] classical simple-virilizing 21OHD, and [3] non-classical 21OHD (NC 21OHD). [1] In classical salt-wasting 21OHD, elevated prenatal androgens cause ambiguous genitalia in the affected female fetus, and aldosterone synthesis is impaired. [2] In classical simple-virilizing 21OHD, aldosterone synthesis is not affected, but affected females present with genital ambiguity. [3] Patients with NC21OHD secrete aldosterone normally, and NC21OHD-affected females do not have genital ambiguity. Screening for 21OHD in the United States (7) indicated that the frequency of NC21OHD was estimated to be 1%. NC21OHD is the most common of all autosomal recessive diseases. NC21OHD is a non-classical variant with mild adrenal 21-hydroxylase deficiency (21OHD), usually presenting in adults without clinical evidence of decreased steroid hormone production (8). We described a 75-year-old woman who had an adrenal crisis. She had elevated serum levels of the cortisol precursor 17-OH-progesterone after ACTH stimulation. She did not have clinical signs of classical 21OHD. She had non-classical 21OHD (NC21OHD). Computed tomography (CT) revealed enlargement of bilateral adrenal glands. Enlargement of bilateral adrenal glands and an episode of an adrenal crisis with serum cortisol 0.91 μg/dL and plasma ACTH 74 pg/mL suggested that she had congenital adrenal hyperplasia (CAH). They were compatible with NC21OHD. No other causes of adrenal insufficiency could be identified. She developed Graves' hyperthyroidism. It has been expected that Graves' hyperthyroidism may cause an adrenal crisis if the patient also has unrecognized or subclinical adrenocortical disease, although it has not been reported. It is possible that NC21OHD, an extremely frequent disorder which is generally thought to be without significant morbidity, might cause or contribute to adrenal insufficiency when the patients develop Graves' hyperthyroidism. We have seen a patient with unrecognized adrenocortical disease, in whom development of Graves' hyperthyroidism caused an adrenal crisis. She had NC21OHD. Development of Graves' hyperthyroidism caused an adrenal crisis in a patient with previously unrecognized NC21OHD.
In the present patient, basal hormone levels were normal. After ACTH stimulation, 17-OH-progesterone and 17-OHprogesterone/corisol increased 17.3 and 9.2 times, respectively. The ACTH stimulation test indicated that she had 21 OHD. She did not have clinical signs of classical 21OHD. She had non-classical 21OHD (NC21OHD). Usefulness of an ACTH stimulation test has been shown in the diagnosis of NC21OHD (9) . NC21OHD may remain undiagnosed if an ACTH stimulation test is not performed.
Adrenal insufficiency may culminate in a life-threatening adrenal crisis (10) . Acute stress situations or other coexistent disease can aggravate adrenal failure. Such conditions usually include acute infections or cardiovascular events. It is, however, also well recognized that thyroid hormones accelerate glucocorticoid turnover, so that hyperthyroidism may increase glucocorticoid requirements in subjects on hydrocortisone replacement (11) . We have seen a patient with unrecognized adrenocortical disease, in whom the development of Graves' hyperthyroidism caused an adrenal crisis. She had NC21OHD. Development of Graves' hyperthyroidism caused an adrenal crisis in a patient with NC 21OHD. A patient with NC21OHD, who had not been known to have NC21OHD, developed florid hyperthyroidism that, in turn, contributed to an adrenal crisis.
The present case illustrates the development of Graves' hyperthyroidism in the setting of previously unknown NC21 OHD. From clinical viewpoint, the most important factor is to recognize that such a combination of two conditions, i.e., Graves' hyperthyroidism in the presence of adrenal insufficiency due to NC21OHD, is indeed possible. Graves' hyperthyroidism can cause an adrenal crisis in patients with NC21 OHD. Patients with NC21OHD do not necessarily have any symptoms or signs of adrenal insufficiency, but may have subclinical adrenal insufficiency. Development of Graves' hyperthyroidism in the presence of adrenal insufficiency due to NC21OHD, though rare, is possible; although this has not been described in the literature. Graves' hyperthyroidism can cause an adrenal crisis in such a patient with NC21 OHD. Graves' disease is the most common cause of hyperthyroidism. One percent of the general population is said to have NC21OHD (7) . Some of these patients with NC21 OHD may have Graves' hyperthyroidism. They may have Graves' hyperthyroidism in the presence of adrenal insufficiency due to NC21OHD, and may develop an adrenal crisis. The patient described above developed Graves' hyperthyroidism, which caused an adrenal crisis. Thyroid hormones increase the turnover of cortisol. She developed Graves' hyperthyroidism, which increased the turnover of cortisol. Her adrenal glands failed to keep up with the cortisol requirements. The serum cortisol level decreased to 0.91 μg/dL. She fell into an adrenal crisis. Development of Graves' hyperthyroidism caused an adrenal crisis in this patient with NC21OHD. The ACTH stimulation test increased serum cortisol levels from 12.2 to 23.1 (1.9 times). This cortisol increase was low, indicating the presence of subclinical adrenal insufficiency. Thus development of Graves' hyperthyroidism caused an adrenal crisis.
It should be noted that she had been well until the age of 75 years old, when the development of Graves' hyperthyroidism caused an adrenal crisis. The development of Graves' hyperthyroidism caused an adrenal crisis in a patient with previously unrecognized NC21OHD. She is now taking 20 mg hydrocortisone daily. However, it will be possible that the doses of hydrocortisone might be decreased, since her adrenal insufficiency is mild.
Adrenal insufficiency due to ACTH deficiency or panhypopituitarism may culminate in a life-threatening adrenal crisis (10) . It is also possible that Graves' hyperthyroidism or thyrotoxicosis due to destructive thyroiditis (painless thyroiditis) may cause adrenal crisis in ACTH deficiency or panhypopituitarism due to lymphocytic hypophysitis, pituitary tumor, post-hypophysectomy, etc. Bayram et al (12) reported the association of lymphocytic hypophysitis with Graves' disease.
An adrenal crisis is often an elusive diagnosis that may result in severe morbidity and mortality when undiagnosed or ineffectively treated. We have seen a patient with unrecognized adrenocortical disease, in whom development of Graves' hyperthyroidism caused an adrenal crisis. She had NC21OHD. Development of Graves' hyperthyroidism caused an adrenal crisis in a patient with previously unrecognized NC21OHD.
